Key facts
- This page summarizes Ashley Hall's Form 4 filing for Structure Therapeutics Inc. (GPCR).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2026, 18:20.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Tax liability
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Additional SEC filing notes
Footnote F1
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
Footnote F2
Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.
Footnote F3
Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.
Footnote F4
Voluntary reporting of the acquisition of 225 ADSs by the Reporting Person on May 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan.
Footnote F5
Voluntary reporting of the acquisition of 237 ADSs by the Reporting Person on November 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan.